PPI link to bone density issues

Australian researchers have urged caution over the use of PPIs in elderly women after finding a link to increased osteoporosis and fracture risk.

The use of PPIs is associated with a 50% higher rate of osteoporosis medication use and up to a twofold higher rate of fractures, according to a prospective cohort study of 4432 women over the age of 76.

Of the 2328 women using PPIs, 36% became users of